Selinexor, Pomalidomide, and Dexamethasone For Multiple Myeloma With CNS Involvement
Clinical trial NCT05478993 · UNKNOWN
Trial details
- NCT number
- NCT05478993
- Sponsor
- Peking University People's Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-12
- Primary completion
- 2024-07-10
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.